HHS orders more monkeypox vaccine
The Department of Health and Human Services July 1 ordered an additional 2.5 million doses of Bavarian Nordic's JYNNEOS, an FDA-licensed vaccine for prevention of smallpox and monkeypox, for use in responding to current or future monkeypox outbreaks and as part of the nation’s smallpox preparedness. Deliveries from this latest order will begin arriving at the Strategic National Stockpile later this year and will continue through early 2023.
This order brings the total vaccine doses to be delivered in 2022 and 2023 to more than 4 million. As of July 1, the CDC has reported approximately 460 U.S. cases of monkeypox.
Related News Articles
Headline
Pediatric sepsis is "an aggressive and unrelenting adversary that knows neither geographic nor demographic bounds," writes Chris DeRienzo, M.D., AHA’s senior…
Headline
Centers for Disease Control and Prevention and state and territorial public health officials Friday met to discuss preparedness planning for bird flu after one…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
AHA is looking forward to spring and March Madness in its latest social media toolkit for hospitals’ and health systems’ use to promote vaccination against the…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
The Centers for Disease Control and Prevention has released a five-part webinar series on its Hospital Sepsis Program Core Elements, which offer guidance to…